The global burden of osteoarthritis knee: a secondary data analysis of a population-based study

医学 入射(几何) 人口学 队列 流行病学 疾病负担 人口 骨关节炎 痹症科 环境卫生 内科学 病理 替代医学 物理 社会学 光学
作者
Jia-Le Ren,Junnan Yang,Weiping Hu
出处
期刊:Clinical Rheumatology [Springer Nature]
标识
DOI:10.1007/s10067-025-07347-6
摘要

Osteoarthritis knee poses a substantial and pervasive global health challenge. The data was extracted from the Global Burden of Disease 2021 Study database. First, numbers and age-standardized rates (ASRs) of incidence, prevalence, and disability-adjusted life years (DALYs) of osteoarthritis knee were assessed globally and by sub-types in 2021. Subsequently, we employed a linear regression model to analyze the temporal trends from 1990 to 2021. To predict the future burden, we utilized the age-period-cohort model and the Bayesian age-period-cohort model. Furthermore, we conducted a sensitivity analysis using the Autoregressive Integrated Moving Average model and the Exponential Smoothing model. In 2021, osteoarthritis knee accounted for 30.85 million incidence cases, 374.74 million prevalence cases, and 12.02 million DALYs cases globally, with ASRs of 353.67, 4294.27, and 137.59, respectively. Females and individuals over 50 years old were identified as high-risk populations, while higher socio-demographic index regions emerged as high-risk areas. From 1990 to 2021, incidence cases rose from 14.13 million to 30.85 million, prevalence cases from 159.80 million to 374.74 million, and DALYs cases from 5.15 million to 12.02 million, accompanied by increases in their respective ASRs. Projections using the APC model predict a continued increase in incidence, prevalence, and DALYs cases for both genders until 2046. Specifically, male incidence cases are projected to increase to 18.45 million and female incidence to 25.60 million. Similarly, male prevalence cases are projected to rise to 235.41 million and female prevalence to 365.97 million. Male DALYs cases are expected to increase to 7.52 million and female DALYs to 11.55 million. The BAPC models also indicate an upward trend in number of cases. In conclusion, osteoarthritis knee represents a formidable threat to global public health, necessitating the development of proactive and tailored strategic interventions that account for global-specific contexts. Key Points • Females and individuals over 50 years old were identified as high-risk populations. • Higher socio-demographic index regions were identified as high-risk areas. • The disease burden attributable to osteoarthritis knee increased from 1990 to 2019. • The number of deaths and DALYs cases would still increase in the next 25 years.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
充电宝应助shan采纳,获得10
3秒前
聪明纲完成签到,获得积分10
6秒前
bi完成签到 ,获得积分10
7秒前
luoshiwen发布了新的文献求助10
8秒前
8秒前
科研通AI6.1应助天真千易采纳,获得10
10秒前
科研通AI6.1应助天真千易采纳,获得100
10秒前
聪明纲发布了新的文献求助10
12秒前
圆红完成签到 ,获得积分10
12秒前
13秒前
luobote完成签到 ,获得积分10
15秒前
瞬间发布了新的文献求助10
15秒前
科研通AI6.2应助天真千易采纳,获得10
16秒前
18秒前
CJY完成签到 ,获得积分10
19秒前
xwt3628完成签到,获得积分10
25秒前
寄语明月完成签到,获得积分10
25秒前
luoshiwen完成签到,获得积分10
28秒前
32秒前
科研通AI6.3应助poki采纳,获得10
32秒前
77完成签到 ,获得积分10
34秒前
farah完成签到 ,获得积分10
35秒前
Jasper应助shan采纳,获得10
36秒前
38秒前
PIngguo发布了新的文献求助10
38秒前
争当科研巨匠完成签到,获得积分10
39秒前
苏su完成签到 ,获得积分10
40秒前
44秒前
得鹿梦鱼完成签到 ,获得积分10
45秒前
48秒前
酷波er应助贾方硕采纳,获得10
48秒前
49秒前
步步高完成签到,获得积分10
49秒前
科研通AI6.1应助天真千易采纳,获得10
50秒前
科研通AI6.1应助天真千易采纳,获得10
50秒前
科研通AI6.2应助天真千易采纳,获得10
50秒前
科研通AI6.3应助天真千易采纳,获得10
50秒前
51秒前
51秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Social Cognition: Understanding People and Events 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6028463
求助须知:如何正确求助?哪些是违规求助? 7690915
关于积分的说明 16186572
捐赠科研通 5175617
什么是DOI,文献DOI怎么找? 2769611
邀请新用户注册赠送积分活动 1753067
关于科研通互助平台的介绍 1638833